Analyst Reco. Abbott Laboratories Swiss Exchange

Equities

ABT

US0028241000

Market Closed - Swiss Exchange Other stock markets 10:01:05 19/02/2024 pm IST			5-day change	1st Jan Change
93 ^CHF	-.--%		-.--%	-.--%

04:42pm	Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit	MT
09/05	Drugmaker Abbott India posts Q4 profit rise on higher sales	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing	09/05	MT
Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126	23/04	MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating	22/04	MT
UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept	19/04	MT
RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating	18/04	MT
Raymond James Adjusts Abbott Laboratories' Price Target to $124 From $127, Keeps Outperform Rating	18/04	MT
Citigroup Raises Price Target on Abbott Laboratories to $128 From $126, Keeps Buy Rating	03/04	MT
Barclays Raises Abbott Laboratories' Price Target to $141 From $133, Keeps Overweight Rating	27/01	MT
Raymond James Adjusts Price Target on Abbott Laboratories to $127 From $124, Maintains Outperform Rating	25/01	MT
Citigroup Raises Abbott Laboratories Price Target to $126 From $123, Maintains Buy Rating	25/01	MT
Bernstein Raises Abbott Laboratories Price Target to $133 From $125, Maintains Outperform Rating	25/01	MT
JPMorgan Raises Abbott Laboratories Price Target to $125 From $122, Maintains Overweight Rating	25/01	MT
UBS Raises Abbott Laboratories Price Target to $136 From $122, Maintains Buy Rating	22/01	MT
Wall St Week Ahead-Maligned US real estate sector draws buyers eyeing rate cuts	21/01	RE
Wall St Week Ahead-Maligned US real estate sector draws buyers eyeing rate cuts	20/01	RE
RBC Adjusts Abbott Laboratories' Price Target to $128 From $119, Keeps Outperform Rating	11/01	MT
Raymond James Raises Abbott Laboratories' Price Target to $124 From $110, Maintains Outperform Rating	03/01	MT
Wells Fargo Raises Price Target on Abbott Laboratories to $121 From $116, Maintains Overweight Rating	13/12	MT
UBS Raises Abbott Laboratories Price Target to $122 From $118, Maintains Buy Rating	19/23/19	MT
Wells Fargo Cuts Price Target on Abbott Laboratories to $116 From $136, Maintains Overweight Rating	19/23/19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Abbott Laboratories Swiss Exchange

Equities

ABT

US0028241000

Analyst Reco.

Filters